Author Archives: IDT Biologika

IDT Biologika on the importance of oncolytic viruses in CGT development

IDT Biologika is a globally operating biopharmaceutical CDMO that specializes in the Contract Development and Manufacturing of vaccines, cell & gene therapeutics including oncolytic viruses, viral vectors, and other biologics for sterile liquid and lyophilized products. Through the utilization of our innovative technologies, we help our clients to advance their prophylactic and therapeutic products to treat serious diseases that impact human health worldwide. How IDT Biologika can support you with Cell & Gene Therapy inquiries was discussed in the following…